The hormone of darkness: melatonin could hurt memory formation at nightNovember 16, 2007HOUSTON - What do you do when a naturally occurring hormone in your body turns against you? What do you do when that same hormone - melatonin - is a popular supplement you take to help you sleep? A University of Houston professor and his team of researchers may have some answers. Gregg W. Roman, assistant professor in the department of biology and biochemistry at UH, describes his team's findings in a paper titled "Melatonin Suppresses Nighttime Memory Formation in Zebrafish," appearing Nov. 16 in Science, the world's leading journal of original scientific research, global news and commentary. Frequently called "the hormone of darkness," melatonin is a hormone the body produces that may regulate patterns of sleeping and awakening in humans. In almost all organisms tested, this antioxidant's natural levels are high during the night and low during the day. In addition to what the body produces naturally, many people also take melatonin supplements to fight jet lag, balance out seasonal affect disorder and regulate nighttime dementia. Roman says, however, that melatonin could actually be hurting you at night, finding in a study with zebrafish (Danio rerio) that melatonin directly inhibits memory formation. "This work is about the mechanism by which the biological clock controls the formation of new memories," Roman said. "We were interested in the circadian control - the day-night cycle control - of learning and memory formation. We found zebrafish are capable of learning very well during their active phase during the day, but learn very poorly at night during their sleep or quiet phase." The experiments were performed using zebrafish for several reasons. They're small and breed in large numbers (thereby being less expensive to use), and they are diurnal, having the same activity rhythms as people. Zebrafish are most active during the day and less active at night, whereas many other vertebrate model systems, such as rodents, are nocturnal. Roman reasons that if you are interested in how the biological clock regulates cognitive function in humans, you should use a model system that reacts to the clock the same way people do. More than two years worth of work, including the discovery that the ability to learn and remember was controlled by an endogenous (or internal) clock originating within the zebrafish, led Roman and his colleagues to hypothesize that melatonin may be responsible for poor learning and memory formation during the night. In order to test whether melatonin was involved in inhibiting nighttime learning and memory formation, they treated the zebrafish during the day with this hormone to see how the fish performed. Interestingly, melatonin failed to affect learning, but dramatically inhibited the formation of new memories, with the melatonin-treated fish resembling fish trained during the night in a test for 24-hour memory. "The next step was to inhibit melatonin signaling during the night with a melatonin receptor antagonist and test for effects on memory formation," Roman said. "It was tremendous - the results were, excuse the expression, like night and day. We saw dramatic improvements in nighttime memory formation by inhibiting melatonin signaling, indicating that the reason the zebrafish did not form memories at night was because of the melatonin hormone." Next, with the pineal gland being the primary source of melatonin in fish and in people, Roman's student Oliver Rawashdeh removed this gland from the fish and found they could now form memories at high levels even during the night. Removing this melatonin-producing gland allowed the researchers to alleviate the hormone's negative side effects, further demonstrating that melatonin inhibits the formation of new memories during the night. With these findings, Roman hopes to be able to retain the beneficial effects of melatonin's antioxidant properties. Such benefits include fighting free radical damage to slow some forms of neurodegeneration, such as in Parkinson's and Alzheimer's diseases, and stopping DNA damage, which has potential to act as a preventative against cancer. And, since the positive antioxidant effect is direct and independent of receptor signaling, there is hope that removing the melatonin receptor signaling will combat only this hormone's negative effects on cognitive function. Additionally, Roman said that inhibiting melatonin signaling with receptor antagonists may help with a large number of nighttime cognitive tasks, helping such people as students studying for finals, airplane pilots, ER physicians and night-shift workers. Roman also thinks that a natural role of melatonin may be to facilitate the storage of memories made during the day and that more studies are required to understand the ultimate role melatonin has in memory formation. "The value of melatonin as a supplement is largely due to its antioxidant properties," Roman said. "The use of melatonin receptor antagonists will not affect this attribute, but may alleviate an important side effect on nighttime cognitive function." In other words, a 'best of both worlds' scenario could result, taking advantage of melatonin's antioxidant benefits while improving nighttime memory formation that is now inhibited by it. Roman's team at UH for this breakthrough study includes Gregory M. Cahill, associate professor of biology and biochemistry, and two of their students and research assistants, Oliver Rawashdeh and Nancy Hernandez de Borsetti. University of Houston |
|||||||||||||||||||||
| Related Melatonin Current Events and Melatonin News Articles Mary had a lot of lambs: Researchers identify way to accelerate sheep breeding Mary had a little lamb, but only once a year. However, Cornell Sheep Program researchers have discovered an unusual form of a gene that prompts ewes to breed out of season as well as conceive at younger ages and more frequently. 105-Day Mars Simulation: U.S. studies focus on improving work performance From March 31 to July 14, a six-man international crew called an isolation chamber in Moscow their home. The crew, composed of four Russians and two Europeans, simulated a 105-day Mars mission full of experiments and realistic mission scenarios, including emergency situations and 20-minute communications delays. Hormone treatment eases post-surgery distress in children A scary unknown for many children, the prospect of surgery can cause intense preoperative anxiety. Melatonin is an effective treatment for sleep problems in children with autism A study in the April 15 issue of the Journal of Clinical Sleep Medicine determined that over-the-counter melatonin medication can shorted the length of time it takes for children with autistic spectrum disorder (ASD), Fragile X Syndrome (FXS), or both to fall asleep at the beginning of the night. Melatonin may be served as a potential anti-fibrotic drug In China, the incidence of liver cirrhosis is still high. Liver cirrhosis results from fibrosis. If treated properly at fibrosis stage, cirrhosis can be prevented. Preventium is 'where the prevention of breast and prostate cancer begins' Dr. Ercole Cavalieri and Dr. Eleanor Rogen of the University of Nebraska Medical Center, Eppley Institute for Research in Cancer, located in Omaha, Nebraska, have identified the triggering mechanism by which breast and prostate cancer cells begin. New genes present drug targets for managing cholesterol and glucose levels Scientists have identified 12 new genes that are somewhat strange bedfellows: Some link gallstones and blood cholesterol levels, others link melatonin and sleep patterns to small increases in glucose levels and larger jumps in the risk of diabetes. Body clock linked to diabetes and high blood sugar in new study Diabetes and high levels of blood sugar may be linked to abnormalities in a person's body clock and sleep patterns, according to a genome-wide association study published today in the journal Nature Genetics. Discovery of new gene associated with diabetes risk suggests link with body clock A connection between the body clock and abnormalities in metabolism and diabetes has been suggested in new research by an international team involving the University of Oxford, the Wellcome Trust Sanger Institute and the MRC Epidemiology Unit in Cambridge. New medication brings hope of jet lag cure A team of researchers from Monash University, The Brigham and Women's Hospital (Boston), Harvard Medical School and Vanda Pharmaceuticals has found a new drug with the potential to alleviate jet lag and sleep disorders caused by shift work. More Melatonin Current Events and Melatonin News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||